Atlas Trials

THINC-it Vortioxetine - Sensitivity to Change

Clinical trial NCT03053362 · COMPLETED

Trial details

NCT number
NCT03053362
Sponsor
Brain and Cognition Discovery Foundation
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Major Depressive DisorderCognitive Change
Start date
2017-05-24
Primary completion
2018-08-08
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.